Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE787.2062.6 (+8.64 %)

PREV CLOSE ( ) 724.60

OPEN PRICE ( ) 774.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 33162

TODAY'S LOW / HIGH ( )754.20 794.80

52 WK LOW / HIGH ( )597.95 876.75

NSE787.1063.75 (+8.81 %)

PREV CLOSE( ) 723.35

OPEN PRICE ( ) 750.00

BID PRICE (QTY) 787.10 (214)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 702089

TODAY'S LOW / HIGH( ) 750.00 794.00

52 WK LOW / HIGH ( )598.6 875.65

Chairman	Gangadi Madhukar Reddy
Managing Director	Gangadi Madhukar Reddy
Company Secretary	Manoj Kumar Srivastava
Non Executive Independent Director	Murali Sivaraman Madhavan Ganesan Aparna Surabhi
Whole Time Director	Cherukupalli Bhaskar Reddy

Incorporation Year : 30-11 2006

Registered Office :

Address : H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally Hyderabad,
Telangana-500037 .

Phone : 040-67246724

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE